OPPORTUNITIES OF ECHOCARDIOGRAPHY IN DIAGNOSTICS OF HEART LESIONS IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Abstract
Heart lesions in systemic lupus erythematosus (SLE) are detected in a half of patients, but in most cases it has no clear clinical symptoms and can be revealed only during instrumental diagnostics. 40 children with SLE and 40 conditionally healthy children were examined in this study. The signs of pericardium lesion were detected in 50% of children with SLE, cardiac valves (aortal and mitral) — in 23% of patients, hypertrophy of myocardium of left ventricle — in 33%, dilatation of its camera — in 20%, disorders of diastolic function — in 12,5%, and decrease of contractility of myocardium — in 15%. In total, the signs of myocardium lesions were detected in children and adolescents with SLE more frequently, and valvulitis — rarely than in adults (according to literature data). Revealed differences in heart structure may reflect peculiarities of disease in children and adverse effects of immunosuppressive therapy.
Key words: children, systemic lupus erythematosus, echocardiography, pericarditis, myocarditis, endocarditis.
(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(3):43-49)
About the Authors
A.B. SugakRussian Federation
E.I. Alexeeva
Russian Federation
I.V. Dvoryakovskiy
Russian Federation
References
1. Подчерняева Н.С., Солнцева О.А., Соболева М.К., Щербакова М.Ю. Системная красная волчанка. Педиатрическая фармакология. 2006; 3 (6): 21–28.
2. Tincani A., Biasini Rebaioli C., Taglietti M., Shoenfeld Y. Heart involvement in systemic lupus erythematosus, antiphospholipid syndrome and neonatal lupus. Rheumatology. 2006; 45 (4): 8–13.
3. Cassidy J.T., Petty R.E. The textbook of pediatric rheumatology. Philadelphia: W.B. Saunders. 2001: 408–409.
4. Sherer Y., Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 2006; 2 (2): 99–106.
5. Sarzi-Puttini P., Atzeni F., Carrabba M. Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome. Minerva Med. 2003; 94 (2): 63–70.
6. Cervera R., Khamashta M.A., Font J. et al. Morbidity and mortality in systemic lupus erythematosus during a 5 year period: a multicenter prospective study of 1000 patients. Medicine. 1999; 78: 167–175.
7. Делягин В.М. Эхокардиография в диагностике поражения сердца при системной красной волчанке, склеродермии и дерматомиозите у детей. Автореф. дис. … канд. мед. наук. М. 1982. 24 с.
8. Doherty N.E., Siegel R.J. Cardiovascular manifestations of systemic lupus erythematosus. Am. Heart. J. 1985; 110 (6): 1257–1265.
9. Bulkley B.H., Roberts W.C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am. J. Med. 1975; 58(2): 243-264.
10. Maksimovic R., Seferovic P.M., Ristic A.D. et al. Cardiac imaging in rheumatic diseases. Rheumatology. 2006; 45 (4): 26–31.
11. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40 (9): 1725.
12. Miyakis S., Lockshin M.D., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J. Thromb. Haemost. 2006; 4 (2): 295–306.
13. Вилкенсхоф У., Крук И. Справочник по эхокардиографии. М.: Мед. лит. 2007. 240 с.
14. Daniels S.R., Kimball T.R., Morrison J.A. et al. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am. J. Cardiol. 1995; 76 (10): 699–701.
15. Gunal N., Kara N., Akkok N. et al. Cardiac abnormalities in children with systemic lupus erythematosus. Turk. J. Pediatr. 2003; 45 (4): 301–305.
16. Moyssakis I., Tektonidou M.G., Vasilliou V.A. et al. Libman–Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am. J. Med. 2007; 120 (7): 636–642.
17. Rantapaa–Dahlqvist S., Neumann–Andersen G., Backman C. et al. Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin. Rheumatol. 1997; 16(2): 140–148.
18. Roldan C.A., Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. Minerva Cardioangiol. 2009; 57 (4): 467–481.
19. Фатхутдинова А.Ф. Поражение сердечно-сосудистой системы у детей с системной красной волчанкой и ювенильным дерматомиозитом. Автореф. дис. … канд. мед. наук. М. 2008. 24с.
20. Levy D., Murabito J.M., Anderson K.M. et al. Echocardiographic left ventricular hypertrophy: clinical characteristics: the Framingham Heart Study. Clin. Exp. Hypertens. 1992; 14: 85–97.
21. Lorell B.H., Carabello B.A. Left ventricular hypertrophy. Pathogenesis, detection and prognosis. Circulation. 2000; 102: 470–476.
Review
For citations:
Sugak A., Alexeeva E., Dvoryakovskiy I. OPPORTUNITIES OF ECHOCARDIOGRAPHY IN DIAGNOSTICS OF HEART LESIONS IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Current Pediatrics. 2010;9(3):43-49.
Email this article 
